Myasthenia Gravis Foundation of America
The Myasthenia Gravis Foundation of America is is dedicated to improving the condition of patients with Myasthenia Gravis, a rare autoimmune disorder leading to muscle weakness. The Foundation funds several research schemes, including those fostering high-impact pilot projects, research that have transformative potential for patients with Myasthenia Gravis, and programs that support early career investigators.
The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.
Final closing date: October 1, 2021